Related Experiment Video
Updated: May 26, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
[Clinical characteristics of the neurological forms of Gaucher's disease]
José Luis Capablo Liesa1, Alicia Sáez de Cabezón, Raquel Alarcia Alejos
1Servicio de Neurología, Hospital Universitario Miguel Servet, Zaragoza, Spain. jcapablo@gmail.com
Abstract:
Gaucher's disease is the most prevalent disease of accumulation of glycosphingolipids. Neurological involvement is used to classify the different types of the disease. Type 1 affects approximately 90% of patients, and visceral manifestations and bone marrow, without affecting the nervous system. Type 2 is considered a severe form of disease with severe nervous system and death within two years. Type 3 is late, slowly progressive neurological symptoms and survival until the third decade. Besides these classical syndromes, the best knowledge of the disease related to the existence of national registries, the increased survival of patients resulting from replacement therapy, and demonstration of the behavior of glucocerebrosidase mutations as a risk factor of neurodegenerative diseases, has expanded the clinical phenotype and altered the traditional classification of the disease.
Related Concept Videos
Lysosomal Hydrolases
Alzheimer Disease ll: Pathophysiology
Parkinson Disease ll: Pathophysiology
Huntington Disease l: Introduction
Alzheimer Disease l: Introduction
Parkinson's Disease: Overview

